InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

KORU Medical Systems, Inc.

KRMD Clue Score65
United States Fiscal year ends December CIK 0000704440
$2.96 -1.33% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.96 +7.25% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue12.3Operating income−0.7Net income−0.5EPS, diluted−0.01Fiscal year 2018Revenue17.4 +41.2%Operating income1.2Net income0.9EPS, diluted0.02Fiscal year 2019Revenue23.2 +33.5%Operating income0.6Net income0.6 −38.0%EPS, diluted0.01 −50.0%Fiscal year 2020Revenue24.2 +4.4%Operating income−1.3Net income−1.2 −314.8%EPS, diluted−0.03 −400.0%Fiscal year 2021Revenue23.5 −2.8%Operating income−7.0Net income−4.6EPS, diluted−0.10Fiscal year 2022Revenue27.9 +18.8%Operating income−10.8Net income−8.7EPS, diluted−0.19Fiscal year 2023Revenue28.5 +2.2%Operating income−10.3Net income−13.7EPS, diluted−0.30Fiscal year 2024Revenue33.6 +18.0%Operating income−6.4Net income−6.1EPS, diluted−0.13Fiscal year 2025Revenue41.1 +22.2%Operating income−3.0Net income−2.6EPS, diluted−0.06
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 12.3 17.4 23.2 24.2 23.5 27.9 28.5 33.6 41.1
Growth +41.2% +33.5% +4.4% −2.8% +18.8% +2.2% +18.0% +22.2%
Operating income −0.7 1.2 0.6 −1.3 −7.0 −10.8 −10.3 −6.4 −3.0
Net income −0.5 0.9 0.6 −1.2 −4.6 −8.7 −13.7 −6.1 −2.6
Growth −38.0% −314.8%
EPS, diluted −0.01 0.02 0.01 −0.03 −0.10 −0.19 −0.30 −0.13 −0.06
Growth −50.0% −400.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin61.6%Operating margin−6.0%Net margin−4.4%Free cash flow margin−4.3%Fiscal year 2018Gross margin62.3%Operating margin6.7%Net margin5.2%Free cash flow margin6.8%Fiscal year 2019Gross margin64.1%Operating margin2.5%Net margin2.4%Free cash flow margin0.5%Fiscal year 2020Gross margin61.8%Operating margin−5.2%Net margin−5.0%Free cash flow margin−6.9%Fiscal year 2021Gross margin58.6%Operating margin−29.9%Net margin−19.4%Free cash flow margin−19.9%Fiscal year 2022Gross margin55.1%Operating margin−38.6%Net margin−31.0%Free cash flow margin−29.3%Fiscal year 2023Gross margin58.6%Operating margin−36.0%Net margin−48.2%Free cash flow margin−19.9%Fiscal year 2024Gross margin63.4%Operating margin−19.2%Net margin−18.0%Free cash flow margin−4.8%Fiscal year 2025Gross margin62.3%Operating margin−7.2%Net margin−6.4%Free cash flow margin−1.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 61.6% 62.3% 64.1% 61.8% 58.6% 55.1% 58.6% 63.4% 62.3%
Operating margin −6.0% 6.7% 2.5% −5.2% −29.9% −38.6% −36.0% −19.2% −7.2%
Net margin −4.4% 5.2% 2.4% −5.0% −19.4% −31.0% −48.2% −18.0% −6.4%
Free cash flow margin −4.3% 6.8% 0.5% −6.9% −19.9% −29.3% −19.9% −4.8% −1.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−0.3Capital expenditure−0.2Free cash flow−0.5Fiscal year 2018Operating cash flow1.5Capital expenditure−0.3Free cash flow1.2Fiscal year 2019Operating cash flow0.3Capital expenditure−0.2Free cash flow0.1 −89.9%Buybacks−0.0Fiscal year 2020Operating cash flow−0.7Capital expenditure−0.9Free cash flow−1.7 −1,493.0%Fiscal year 2021Operating cash flow−4.3Capital expenditure−0.3Free cash flow−4.7Fiscal year 2022Operating cash flow−5.4Capital expenditure−2.8Free cash flow−8.2Fiscal year 2023Operating cash flow−4.9Capital expenditure−0.8Free cash flow−5.7Fiscal year 2024Operating cash flow−0.3Capital expenditure−1.3Free cash flow−1.6Fiscal year 2025Operating cash flow0.5Capital expenditure−0.9Free cash flow−0.5
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 1.5 0.3 −0.7 −4.3 −5.4 −4.9 −0.3 0.5
Capital expenditure −0.2 −0.3 −0.2 −0.9 −0.3 −2.8 −0.8 −1.3 −0.9
Free cash flow −0.5 1.2 0.1 −1.7 −4.7 −8.2 −5.7 −1.6 −0.5
Growth −89.9% −1,493.0%
Buybacks n/a n/a −0.0 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash3.3Shareholders’ equity6.7Fiscal year 2018Cash3.7Shareholders’ equity9.0Fiscal year 2019Cash5.9Shareholders’ equity11.2Fiscal year 2020Cash27.3Shareholders’ equity36.2Fiscal year 2021Cash25.3Shareholders’ equity36.5Fiscal year 2022Cash17.4Shareholders’ equity31.3Fiscal year 2023Cash11.5Shareholders’ equity20.4Fiscal year 2024Cash9.6Shareholders’ equity16.8Fiscal year 2025Cash8.9Shareholders’ equity17.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.3 3.7 5.9 27.3 25.3 17.4 11.5 9.6 8.9
Shareholders’ equity 6.7 9.0 11.2 36.2 36.5 31.3 20.4 16.8 17.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 28 Feb 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
12.3 17.4 23.2 24.2 23.5 27.9 28.5 33.6 41.1
Growth +41.2% +33.5% +4.4% −2.8% +18.8% +2.2% +18.0% +22.2%
n/a 6.5 8.3 9.2 9.7 12.5 11.8 12.3 15.5
7.6 10.8 14.9 14.9 13.8 15.4 16.7 21.3 25.6
Growth +42.8% +37.4% +0.6% −7.8% +11.6% +8.7% +27.7% +20.0%
0.2 0.2 0.7 1.3 2.5 5.0 5.7 5.3 4.4
7.8 8.2 9.8 12.0 17.9 20.6 20.4 21.6 23.4
−0.7 1.2 0.6 −1.3 −7.0 −10.8 −10.3 −6.4 −3.0
Growth −49.7% −314.2%
−0.8 1.2 0.7 1.2 −6.4 −10.7 −9.8 −6.1 −2.6
−0.2 0.3 0.1 −0.0 −1.8 −2.0 4.0 0.0 0.0
−0.5 0.9 0.6 −1.2 −4.6 −8.7 −13.7 −6.1 −2.6
Growth −38.0% −314.8%
Per share
−0.01 0.02 0.01 −0.03 −0.10 −0.19 −0.30 −0.13 −0.06
−0.01 0.02 0.01 −0.03 −0.10 −0.19 −0.30 −0.13 −0.06
Growth −50.0% −400.0%
37.8 38.1 38.8 41.9 44.4 45.0 45.6 45.8 46.2
37.9 38.9 39.1 41.9 44.4 45.0 45.6 45.8 46.2
Growth +2.8% +0.4% +7.3% +5.9% +1.4% +1.3% +0.4% +0.8%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 11.2% a year over five years.
  • The diluted share count rose 10.2% in five years, which is dilution.
  • Operating margin is down 2.0 points on five years ago, at -7.2%.
  • A net loss in 7 of 9 years on file.